Company Search:
Advanced Search
Sponsored Links
Lansen Pharmaceutical Holdings Limited Company Snapshot
Lansen Pharmaceutical Holdings Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lansen Pharmaceutical Holdings Limited with three other companies in this sector in China: Ningbo Menovo Pharmaceutical Co Ltd (2017 sales of 605.32 million Chinese Renmimbi [US$89.55 million] of which 84% was Pharmaceutical manufacture), Chongqing Pharscin Pharmaceutical Co LtdChongqing Pharscin Pharmaceutical Co L td (592.10 million Chinese Renmimbi [US$87.59 million] of which 82% was Medicine Industry), and Chengdu Taihe Health Technology Group Inc Ltd (590.95 million Chinese Renmimbi [US$87.42 million] of which 86% was Medicine Manufacturing).

Sales Analysis. During the year ended December of 2017, sales at Lansen Pharmaceutical Holdings Limited were 602.67 million Chinese Renmimbi (US$89.15 million). This is a decrease of 4.5% versus 2016, when the company's sales were 630.90 million Chinese Renmimbi. The sales level in 2017 was fairly close to the level five years ago: in 2012, Lansen Pharmaceutical Holdings Limited had sales of 591.37 million Chinese Renmimbi. Contributing to the drop in overall sales was the 33.8% decline in Healthcare Products, from 81.94 million Chinese Renmimbi to 54.28 million Chinese Renmimbi. There were also decreases in sales in Medical Cosmetics Produts (down 26.0% to 88.87 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Specialty Pharmaceuticals (up 7.1% to 459.52 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lansen Pharmaceutical Holdings Limited
  Stock Performance Chart for Lansen Pharmaceutical Holdings Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): .82
(Figures in Chinese Renmimbi)
1 Week 1.4%   13 Weeks -0.2%  
4 Weeks -1.6%   52 Weeks -22.9%  
Lansen Pharmaceutical Holdings Limited Key Data:
  Ticker: 503 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 602,666,686
(Year Ending Jan 2018).
Employees: 790
  Currency: Chinese Renmimbi Market Cap: 340,046,850
  Fiscal Yr Ends: December Shares Outstanding: 415,000,000
  Share Type: H Gu Closely Held Shares: 210,420,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.